Moreover, NFκB activation in mesenchymal GBM cells mediates cell migration and tumor invasion through upregulation of NFκB target genes, including cell chemoattractants (IL-8, MCP-1) and matrix metalloproteinases (MMP-9) [106]. The gene discussed is MMP9; the disease is neoplasm.